Translational readthrough as a potential therapeutic for AIPL1-associated Leber Congenital Amaurosis in a patient-derived iPSC-retinal organoid model
Preprint
Abstract
Summary: Leber Congenital Amaurosis type 4 (LCA4), caused by AIPL1 mutations, is characterised by severe sight impairment in infancy and rapidly progressive degeneration of photoreceptor cells. We generated retinal organoids using induced pluripotent stem cells (iPSCs) from renal epithelial cells obtained from four children with AIPL1 nonsense mutations. iPSC-derived photoreceptors exhibited the molecular hallmarks of LCA4, including undetectable AIPL1 and rod cGMP phosphodiesterase (PDE6) compared to control or CRISPR corrected organoids. Moreover, increased levels of cGMP were detected. The translational readthrough inducing drug (TRID) PTC124 was investigated as a potential therapeutic. LCA4 retinal organoids exhibited rescue of AIPL1 and PDE6; however, the level of full-length, functional AIPL1 induced through PTC124 treatment was insufficient to reduce cGMP levels and fully rescue the LCA4 phenotype. LCA4 retinal organoids are a valuable platform for the in vitro investigation of the molecular mechanisms that drive photoreceptor loss and for the evaluation of novel therapeutics.Keywords
This publication has 72 references indexed in Scilit:
- Generating a Non-Integrating Human Induced Pluripotent Stem Cell Bank from Urine-Derived CellsPLOS ONE, 2013
- A comparative evaluation of NB30, NB54 and PTC124 in translational read‐through efficacy for treatment of an USH1C nonsense mutationEMBO Molecular Medicine, 2012
- Gene therapy using self-complementary Y733F capsid mutant AAV2/8 restores vision in a model of early onset Leber congenital amaurosisHuman Molecular Genetics, 2011
- The Leber congenital amaurosis protein, AIPL1, is needed for the viability and functioning of cone photoreceptor cellsHuman Molecular Genetics, 2009
- AIPL1, a Protein Associated with Childhood Blindness, Interacts with α-Subunit of Rod Phosphodiesterase (PDE6) and Is Essential for Its Proper AssemblyJournal of Biological Chemistry, 2009
- RETRACTED ARTICLE: Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutationsGene Therapy, 2009
- Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectorsHuman Molecular Genetics, 2009
- The Leber Congenital Amaurosis Protein AIPL1 Functions as Part of a Chaperone HeterocomplexInvestigative Ophthalmology & Visual Science, 2008
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007